Drug · DIN 02489201
ESCITALOPRAM
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since January 16, 2026; first marketed March 27, 2020.
- Drug Identification Number (DIN)
- 02489201
- Company (DIN owner)
- Nora Pharma Inc.Varennes, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Escitalopram N06AB10
- Class
- Human
- Record last updated
- March 19, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ESCITALOPRAM (ESCITALOPRAM OXALATE) | 20 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 11, 2019: NOC 22270Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
Other DINs named ESCITALOPRAM
- DIN 02424401 · Marketed
- DIN 02424428 · Marketed
- DIN 02429039 · Marketed
- DIN 02429047 · Marketed
- DIN 02429780 · Marketed
- DIN 02429799 · Marketed
- DIN 02430118 · Marketed
- DIN 02430126 · Marketed
- DIN 02438496 · Cancelled Pre Market
- DIN 02438518 · Cancelled Pre Market
- DIN 02466058 · Approved
- DIN 02466066 · Approved
- DIN 02477181 · Approved
- DIN 02477203 · Approved
- DIN 02489171 · Cancelled Post Market
- DIN 02506602 · Cancelled Pre Market
- DIN 02506610 · Cancelled Pre Market
- DIN 02506629 · Cancelled Pre Market
- DIN 02506637 · Cancelled Pre Market